Friday, July 17, 20267 stories
GLP-1 offsets antipsychotic weight gain
Today's medical research brings a promising crossover: GLP-1 drugs, already known for diabetes and obesity, show real weight-loss benefit for schizophrenia patients battling antipsychotic side effects. Meanwhile, new data on focal prostate cancer therapy and air pollution's heart risks round out a day heavy on treatment and prevention angles.
Thursday, July 16, 20266 stories
Huntington's clock, brain implants, and AI pathology
Today's medical research stories share a theme of precision: knowing exactly when a disease starts, where hidden risk lies, and how to intervene with technology. From the decades-long gap in Huntington's to a brain implant that restores movement, the day's pieces focus on timing and targeting.